vs
Side-by-side financial comparison of AbbVie (ABBV) and Coupang, Inc. (CPNG). Click either name above to swap in a different company.
AbbVie is the larger business by last-quarter revenue ($15.0B vs $8.5B, roughly 1.8× Coupang, Inc.). On growth, AbbVie posted the faster year-over-year revenue change (9.9% vs 7.5%). Over the past eight quarters, Coupang, Inc.'s revenue compounded faster (7.8% CAGR vs 1.8%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Coupang, Inc. is an American Delaware-incorporated technology and online retail company headquartered in Seattle, Washington. Founded in 2010 by Bom Kim, the company operates a retail business, food delivery service, and OTT streaming service, with offices and operations in South Korea, Taiwan, the United States, India, Japan and Singapore.
ABBV vs CPNG — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $15.0B | $8.5B |
| Net Profit | $697.0M | — |
| Gross Margin | — | 27.0% |
| Operating Margin | 26.6% | — |
| Net Margin | 4.6% | — |
| Revenue YoY | 9.9% | 7.5% |
| Net Profit YoY | -46.0% | — |
| EPS (diluted) | $0.39 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $15.0B | $8.5B | ||
| Q4 25 | $16.6B | $8.8B | ||
| Q3 25 | $15.8B | $9.3B | ||
| Q2 25 | $15.4B | $8.5B | ||
| Q1 25 | $13.3B | $7.9B | ||
| Q4 24 | $15.1B | $8.0B | ||
| Q3 24 | $14.5B | $7.9B | ||
| Q2 24 | $14.5B | $7.3B |
| Q1 26 | $697.0M | — | ||
| Q4 25 | $1.8B | $-26.0M | ||
| Q3 25 | $186.0M | $95.0M | ||
| Q2 25 | $938.0M | $32.0M | ||
| Q1 25 | $1.3B | $107.0M | ||
| Q4 24 | $-22.0M | $156.0M | ||
| Q3 24 | $1.6B | $70.0M | ||
| Q2 24 | $1.4B | $-77.0M |
| Q1 26 | — | 27.0% | ||
| Q4 25 | 72.6% | 28.8% | ||
| Q3 25 | 66.4% | 29.4% | ||
| Q2 25 | 71.8% | 30.0% | ||
| Q1 25 | 70.0% | 29.3% | ||
| Q4 24 | 70.9% | 31.3% | ||
| Q3 24 | 70.9% | 28.8% | ||
| Q2 24 | 70.9% | 29.3% |
| Q1 26 | 26.6% | — | ||
| Q4 25 | 27.3% | 0.1% | ||
| Q3 25 | 12.1% | 1.7% | ||
| Q2 25 | 31.7% | 1.7% | ||
| Q1 25 | 28.0% | 1.9% | ||
| Q4 24 | -9.9% | 3.9% | ||
| Q3 24 | 26.5% | 1.4% | ||
| Q2 24 | 27.6% | -0.3% |
| Q1 26 | 4.6% | — | ||
| Q4 25 | 10.9% | -0.3% | ||
| Q3 25 | 1.2% | 1.0% | ||
| Q2 25 | 6.1% | 0.4% | ||
| Q1 25 | 9.6% | 1.4% | ||
| Q4 24 | -0.1% | 2.0% | ||
| Q3 24 | 10.8% | 0.9% | ||
| Q2 24 | 9.5% | -1.1% |
| Q1 26 | $0.39 | $-0.15 | ||
| Q4 25 | $1.02 | $-0.02 | ||
| Q3 25 | $0.10 | $0.05 | ||
| Q2 25 | $0.52 | $0.02 | ||
| Q1 25 | $0.72 | $0.06 | ||
| Q4 24 | $-0.03 | $0.08 | ||
| Q3 24 | $0.88 | $0.04 | ||
| Q2 24 | $0.77 | $-0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $6.3B |
| Total DebtLower is stronger | — | $2.3B |
| Stockholders' EquityBook value | — | $3.9B |
| Total Assets | — | $17.4B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $6.3B | ||
| Q4 25 | $5.3B | $6.3B | ||
| Q3 25 | $5.7B | $7.2B | ||
| Q2 25 | $6.5B | $6.8B | ||
| Q1 25 | $5.2B | $6.1B | ||
| Q4 24 | $5.6B | $5.9B | ||
| Q3 24 | $7.3B | $5.8B | ||
| Q2 24 | $13.2B | $5.5B |
| Q1 26 | — | $2.3B | ||
| Q4 25 | $58.9B | $648.0M | ||
| Q3 25 | $63.0B | — | ||
| Q2 25 | $63.0B | — | ||
| Q1 25 | $64.5B | — | ||
| Q4 24 | $60.3B | $988.0M | ||
| Q3 24 | $58.5B | — | ||
| Q2 24 | $58.0B | — |
| Q1 26 | — | $3.9B | ||
| Q4 25 | $-3.3B | $4.6B | ||
| Q3 25 | $-2.6B | $4.7B | ||
| Q2 25 | $-183.0M | $4.7B | ||
| Q1 25 | $1.4B | $4.4B | ||
| Q4 24 | $3.3B | $4.1B | ||
| Q3 24 | $6.0B | $4.2B | ||
| Q2 24 | $6.8B | $3.9B |
| Q1 26 | — | $17.4B | ||
| Q4 25 | $134.0B | $17.8B | ||
| Q3 25 | $133.9B | $18.7B | ||
| Q2 25 | $137.2B | $17.8B | ||
| Q1 25 | $136.2B | $16.0B | ||
| Q4 24 | $135.2B | $15.3B | ||
| Q3 24 | $143.4B | $16.3B | ||
| Q2 24 | $141.9B | $15.2B |
| Q1 26 | — | 0.58× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 45.44× | — | ||
| Q4 24 | 18.15× | 0.24× | ||
| Q3 24 | 9.70× | — | ||
| Q2 24 | 8.56× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $184.0M |
| Free Cash FlowOCF − Capex | — | $-110.0M |
| FCF MarginFCF / Revenue | — | -1.3% |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $297.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $184.0M | ||
| Q4 25 | $5.2B | $82.0M | ||
| Q3 25 | $7.0B | $792.0M | ||
| Q2 25 | $5.2B | $545.0M | ||
| Q1 25 | $1.6B | $354.0M | ||
| Q4 24 | $7.0B | $676.0M | ||
| Q3 24 | $5.4B | $334.0M | ||
| Q2 24 | $2.3B | $664.0M |
| Q1 26 | — | $-110.0M | ||
| Q4 25 | $4.9B | $-278.0M | ||
| Q3 25 | $6.6B | $439.0M | ||
| Q2 25 | $4.9B | $246.0M | ||
| Q1 25 | $1.4B | $115.0M | ||
| Q4 24 | $6.8B | $462.0M | ||
| Q3 24 | $5.2B | $-46.0M | ||
| Q2 24 | $2.0B | $486.0M |
| Q1 26 | — | -1.3% | ||
| Q4 25 | 29.4% | -3.1% | ||
| Q3 25 | 42.1% | 4.7% | ||
| Q2 25 | 31.7% | 2.9% | ||
| Q1 25 | 10.5% | 1.5% | ||
| Q4 24 | 44.7% | 5.8% | ||
| Q3 24 | 35.9% | -0.6% | ||
| Q2 24 | 14.0% | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 4.1% | ||
| Q3 25 | 2.4% | 3.8% | ||
| Q2 25 | 1.7% | 3.5% | ||
| Q1 25 | 1.8% | 3.0% | ||
| Q4 24 | 1.9% | 2.7% | ||
| Q3 24 | 1.7% | 4.8% | ||
| Q2 24 | 1.7% | 2.4% |
| Q1 26 | — | — | ||
| Q4 25 | 2.87× | — | ||
| Q3 25 | 37.76× | 8.34× | ||
| Q2 25 | 5.49× | 17.03× | ||
| Q1 25 | 1.27× | 3.31× | ||
| Q4 24 | — | 4.33× | ||
| Q3 24 | 3.49× | 4.77× | ||
| Q2 24 | 1.66× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
